Introduction
============

The endoscopic gastroesophageal flap valve (GEFV) grading system proposed by Hill et al[@b1-jnm-24-226] allows evaluation of the stepwise relaxation of the gastroesophageal junction. The association between GEFV and gastroesophageal reflux disease (GERD) has been already reported in several previous studies.[@b2-jnm-24-226]--[@b7-jnm-24-226] However, most of these studies were conducted on patients with reflux esophagitis (RE)[@b2-jnm-24-226]--[@b5-jnm-24-226] and there were very few studies on patients with dyspepsia and non-erosive reflux disease (NERD).[@b6-jnm-24-226],[@b7-jnm-24-226] There have been no studies investigating the distribution of abnormal GEFV among patients with dyspepsia, NERD and different grades of RE in the same set of patients. Such studies are important as they can help to shed light on the role of GEFV in the pathophysiology of GERD spectrum.

In clinical practice, differentiating between dyspepsia and GERD may be very challenging. Several types of questionnaires have been suggested for the diagnosis of GERD. A previous study reported that the scores of quality of life and utility evaluation survey technology (QUEST) questionnaire had a positive correlation with GEFV grades.[@b7-jnm-24-226] But a recent study showed that this questionnaire was complicated to complete.[@b8-jnm-24-226] The gastroesophageal reflux disease questionnaire (GERDQ) has been developed as a useful tool to improve and standardize symptom-based diagnosis in patients with GERD.[@b9-jnm-24-226] This questionnaire has been validated in Vietnamese patients but has not been applied to investigate the association between abnormal GEFV and GERD. Our study aims to assess: (1) the association between GEFV abnormality and GERDQ score, and (2) the distribution of abnormal GEFV in Vietnamese patients presenting with dyspepsia, NERD, and RE.

Materials and Methods
=====================

Patients
--------

We conducted a prospective cross-sectional study on patients with upper gastrointestinal symptoms from March 2015 to July 2015 at the University Medical Center, Hochiminh City, Vietnam. We included patients who (1) were at least 18 years of age, (2) had upper gastrointestinal symptoms, and (3) underwent upper gastrointestinal endoscopy. We excluded patients who (1) used antibiotics or proton pump inhibitors (PPIs) within 4 weeks, or (2) had at least one of the following conditions: advanced esophageal or gastric cancer, active upper gastrointestinal bleeding, or prior history of upper gastrointestinal surgery. This study was approved by the Ethics Committee of the University of Medicine and Pharmacy, Hochiminh City, Vietnam (No. 1511-15/DHYD-HD).

Pre-endoscopic Evaluation
-------------------------

Before undergoing upper gastrointestinal endoscopy, all patients filled out the GERDQ score.[@b9-jnm-24-226] The history of smoking and alcohol consumption was recorded. The body mass index (BMI) and waist--hip ratio were calculated for all patients. Obesity was defined as BMI \> 25 kg/m^2^, and central obesity was defined as waist--hip ratio ≥ 0.9 in male or ≥ 0.85 in female according to the World Health Organization criteria.[@b10-jnm-24-226]

Endoscopic Examination
----------------------

Upper gastrointestinal endoscopy was performed using flexible video endoscopy Olympus scope GIF-160 or GIF-Q180 (Olympus Co. Ltd, Tokyo, Japan) under topical anesthesia in each patient. All endoscopic procedures were performed by experienced endoscopists who were blinded from GERDQ score. The esophagus, stomach, and duodenum were examined with optimal visualization. The severity of RE was graded according to Los Angeles classification.[@b11-jnm-24-226] The degree of gastric mucosal atrophy was classified as closed or open type according to the Kimura--Takemoto classification,[@b12-jnm-24-226] and divided into 3 groups: none or mild (C-0, C-1, C-2), moderate (C-3, O-1), and severe (O-2, O-3). The GEFV was inspected with a retroflexed endoscope and graded I to IV according to the Hill classification ([Fig. 1](#f1-jnm-24-226){ref-type="fig"}).[@b1-jnm-24-226] One endoscopist (T.T.N.) evaluated the endoscopic GEFV of all patients in this study. In addition, the GEFV grade in each patient was also evaluated by one another endoscopist from the Department of endoscopy, University Medical Center, Hochiminh City who (1) has an experience to perform upper gastrointestinal endoscopy with at least 5000 procedures over the last 5 years and (2) has attended a previous local training workshop on GEFV evaluation. The GEFV grade in each patient was then decided based on the agreement of these two doctors. If the agreement could not be reached, the still endoscopic images were used to discuss with a senior endoscopist (D.T.Q.) to make the final agreement.

Definitions
-----------

Patients were classified into 3 groups on the basis of upper endoscopic findings and GERDQ score: RE (presence of endoscopic mucosal injury), NERD (GERDQ score ≥ 8, no endoscopic mucosal injury), and dyspepsia (GERDQ score \< 8, no endoscopic mucosal injury). GERD was defined as RE plus NERD. GEFV grades I and II were regarded as representing normal GEFV, while grades III and IV were regarded as representing abnormal GEFV. Sliding hiatus hernia was diagnosed when the apparent separation between the squamocolumnar junction and the diaphragmatic impression is greater than 2 cm.[@b13-jnm-24-226] Patients were considered *Helicobacter pylori* infection when local validated rapid urease test was positive within 1 hour.

Statistical Methods
-------------------

Categorical variables were analyzed using Pearson's chi-squared test, and continuous variables were analyzed using Student's *t* test or one-way analysis of variance. The Spearman's rank correlation coefficient was used to measure the strength and direction of association between ordinal variables. Univariable and multivariable analyses using logistic regression were performed to identify the risk factors for GERD and RE. Patients' age, sex, BMI, alcohol drinking, and smoking status, *H. pylori* infection status and GEFV grades were included in the multivariate logistic regression analysis (age was dichotomized as it was nonlinear). All tests were two-sided and performed at the 5% level of significance. Statistical calculations were performed with SPSS version 19.0 for Windows software (IBM, Armonk, NY, USA).

Results
=======

There were 331 patients in our study. The baseline demographics and clinical characteristics of patients in the study are described in [Table 1](#t1-jnm-24-226){ref-type="table"}. There were 116 (35%) patients diagnosed with GERD. RE was identified in 61 (18.4%) patients: 51 (15.4%) in grade A, 9 (2.7%) in grade B, 1 (0.3%) in grade C, and no patient in grade D. There were 120 (36.2%) patients with abnormal GEFV and 15 (4.5%) patients with hiatus hernia ([Table 2](#t2-jnm-24-226){ref-type="table"}). The rates of hiatal hernia according to GEFV from grade I to grade IV were 0.0% (0/36), 0.0% (0/175), 7.9% (9/114), and 100.0% (6/6), respectively (Spearman's rank correlation coefficient = 0.32; *P* \< 0.001).

In multivariable analysis, abnormal GEFV was an independent risk factor for GERD (OR, 2.93; CI 95%, 1.76--4.88) and RE (OR, 3.41; CI 95%, 1.78--6.53) ([Tables 3](#t3-jnm-24-226){ref-type="table"} and [4](#t4-jnm-24-226){ref-type="table"}). Obesity was a risk factor of RE (OR, 2.59; CI 95%, 1.15--5.85), but the statistical significance was marginal for GERD. *H. pylori* infection was a significant preventive factors for GERD (OR, 0.49; CI 95%, 0.29--0.82) and RE (OR, 0.16; CI 95%, 0.07--0.36).

The mean GERDQ score of patients with abnormal GEFV was significantly higher than that of patients with normal GEFV: 5.7 ± 2.7 vs 4.9 ± 2.4, respectively (*P* = 0.011) ([Table 5](#t5-jnm-24-226){ref-type="table"}). [Figure 2](#f2-jnm-24-226){ref-type="fig"} summarises the distribution of abnormal GEFV among patients with upper gastrointestinal disorders. The prevalence of abnormal GEFV gradually increased in subgroups of patients with dyspepsia (59/215, 27.4%), NERD (24/55, 43.6%), grade A RE (29/51, 56.8%), and grades B/C RE (8/10, 80%) (P \< 0.001).

Discussion
==========

There were very few Asian data about the prevalence of abnormal GEFV. Iwamoto et al[@b7-jnm-24-226] reported that the prevalence of abnormal GEFV in Japan was 13.5% with a total GERD prevalence of 27.0% among patients undergoing endoscopic examination. In another study in Taiwan, Lin et al[@b6-jnm-24-226] reported that the prevalence of abnormal GEFV was 27.3% with a total GERD prevalence of 41.3% among subjects undergoing routine check-ups. Our study showed that abnormal GEFV is an independent risk factor of GERD in multivariable analysis (OR, 2.93; CI 95%, 1.76--4.88; *P* \< 0.001). This finding helps to partially explain why GERD prevalence increases in parallel with the prevalence of abnormal GEFV in the 2 above-mentioned populations.

Some previous Asian studies reported that abnormal GEFV was a risk factor of RE, and associated with RE severity in adults as well as in pediatric patients.[@b2-jnm-24-226]--[@b4-jnm-24-226],[@b7-jnm-24-226] Our study also confirmed this finding in Vietnamese population. It is well known that the prevalence of RE in Caucasian population is higher than that in Asian population.[@b14-jnm-24-226] A recent study on Russian Caucasians and Koreans patients showed that abnormal GEFV was an independent risk factor of RE regardless of ethnicity.[@b5-jnm-24-226] Interestingly, the prevalences of abnormal GEFV and RE in the former population were both significantly higher than those in the later (44.2% vs 28.5%, *P* \< 0.001; 20.2% vs 9.8%, *P* \< 0.001, respectively). Although hiatus hernia has been identified as an independent risk factor of GERD, its prevalence in Asian populations is substantially lower than those reported in Western populations.[@b15-jnm-24-226] In our study, there were only 15 (4.5%) patients with hiatus hernia. All of these patients were with GEFV types III and IV. Therefore, abnormal GEFV could be a more sensitive risk factor of GERD in Asian populations compared to hiatus hernia.

There are very few studies investigating the distribution of abnormal GEFV on patients with dyspepsia and NERD.[@b6-jnm-24-226],[@b7-jnm-24-226] NERD accounts for the majority of GERD patients in clinical practice. It is a heterogeneous group which consists of patients who have no endoscopic RE but (1) increased acid exposure time, or (2) normal acid exposure time but positive symptom-associated probability, or (3) normal acid exposure time and negative symptom-associated probability (functional heartburn).[@b16-jnm-24-226] Studying the distribution of abnormal GEFV among patients with dyspepsia, NERD, and RE may help to predict the subgroups of NERD with actually having increased reflux events. In a previous study, Koch et al reported that there was a significant positive correlation between increased GEFV grade and DeMeester score, total number of reflux events and acid reflux events.[@b17-jnm-24-226] Our study showed that GERDQ score in patients with abnormal GEFV was significantly higher compared to patients with normal GEFV (5.7 ± 2.4 vs 4.9 ± 2.7, *P* = 0.011) ([Table 5](#t5-jnm-24-226){ref-type="table"}). The prevalence of abnormal GEFV also gradually increased among patients with dyspepsia, NERD, grade A, and grades B/C RE, respectively ([Fig. 2](#f2-jnm-24-226){ref-type="fig"}). In the dyspepsia group of our study, there were 59 (27.4%) out of 215 patients having abnormal GEFV. According to the finding from the above-mentioned study by Koch et al,[@b17-jnm-24-226] these patients might already have a higher number of acid reflux and reflux events compared with the rest patients in the dyspepsia group, but not yet enough to fulfill the definition of GERD. However, they are more likely to develop GERD in the future when other risk factors of GERD involve. In clinical practice, we have found some patients changing symptoms from dyspepsia to typical reflux during follow-up. The changes of other risk factors of GERD in these patients such as aging, smoking status, obesity may play important roles on the development of GERD.

*H. pylori* infection is a "protective" factor for GERD as shown in our study and a recent study in Korea,[@b5-jnm-24-226] while the infection is considered an important cause of dyspepsia.[@b18-jnm-24-226] Inoue et al[@b19-jnm-24-226] reported that Japanese patients after successful eradication of the bacteria were more likely to suffer from RE. This study also showed that the pH level of gastric juice after eradication therapy was lower in the group of patients with successful eradication than in the group with failed therapy. In addition, the incidence of RE after *H. pylori* eradication was significantly higher in patients with abnormal GEFV compared to patients with normal GEFV (33.3% vs 16.3%, *P* = 0.04). Therefore, the current evidence suggests that abnormal GEFV is an important risk factor for a diverse spectrum of gastroesophageal reflux phenomenon: from an episode with increased reflux events but not yet fulfilled the definition of GERD to a real GERD.

On the other end of the spectrum, 8 (80%) out of 10 patients with grades B/C RE in our study had abnormal GEFV, suggesting that abnormal GEFV contributes an important role on severe RE. Some studies also reported that abnormal GEFV was associated with poor response to PPI treatment, more PPIs usage during on demand therapy after remission and surgery indication for either failed medical management or complications.[@b3-jnm-24-226],[@b20-jnm-24-226],[@b21-jnm-24-226]

Our study has some limitations. Firstly, it is a single-center study with relatively small number of patients. Secondly, the number of patients with severe RE (ie, grades C and D) in our study is small. As a consequence, the prevalence of abnormal GEFV in severe RE has not been fully investigated in this study.

In conclusion, our study showed that abnormal GEFV was an independent risk factor of GERD and significantly associated with high GERDQ score in Vietnamese patients with upper gastrointestinal symptoms. The prevalence of abnormal GEFV increased gradually among patients with dyspepsia, NERD, and RE.
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![Endoscopic gastroesophageal flap valve assessment. Grade I: gastroesophageal flap valve (GEFV) with a prominent fold or ridge of tissue along the lesser curvature closely apposed to the endoscope. Grade II: GEFV with a less prominent ridge, opening rarely with respiration and closing promptly. Grade III: fold not prominent; the endoscope was not gripped tightly by the tissues and often failed to close around the endoscope. Grade IV: fold absent with the lumen of the esophagus gaping open, allowing squamous epithelium to be viewed from below.](jnm-24-226f1){#f1-jnm-24-226}

![Abnormal gastroesophageal flap valve (GEFV) prevalence in upper gastrointestinal disorders. NERD, non-erosive reflux disease; RE, reflux esophagitis. Pearson's chi-squared test, *P* \< 0.001.](jnm-24-226f2){#f2-jnm-24-226}

###### 

Baseline Demographics and Clinical Characteristics of Patients in the Study

  Variables                                                             Dyspepsia (n = 215)   NERD (n = 55)   RE (n = 61)   *P*-value
  --------------------------------------------------------------------- --------------------- --------------- ------------- -----------
  Male gender (n \[%\])                                                 88 (40.9)             30 (54.5)       41 (67.2)     0.001
  Age (mean ± SD, yr)                                                   36.4 ± 11.9           38.1 ± 9.7      39.7 ± 12.3   0.120
  BMI (mean ± SD, kg/m^2^)                                              21.4 ± 2.9            21.8 ± 2.9      23.3 ± 3.4    \< 0.001
  Obesity[a](#tfn1-jnm-24-226){ref-type="table-fn"} (n \[%\])           26 (12.1)             9 (16.4)        20 (32.8)     0.001
  WHR (mean ± SD)                                                       0.80 ± 0.06           0.83 ± 0.06     0.85 ± 0.07   \< 0.001
  Central obesity[a](#tfn1-jnm-24-226){ref-type="table-fn"} (n \[%\])   58 (27)               16 (29.1)       21 (34.4)     0.524
  Smoking (n \[%\])                                                     43 (20)               17 (30.9)       28 (45.9)     0.001
  Alcohol drinking (n \[%\])                                            72 (33.5)             22 (40)         29 (47.5)     0.120
  *H. pylori* infection (n \[%\])                                       102 (47.4)            28 (50.9)       9 (14.8)      \< 0.001

Obesity was defined as body mass index (BMI) \> 25kg/m^2^ and central obesity was defined as waist--hip ratio (WHR) ≥ 0.9 in male or ≥ 0.85 in female according to the World Health Organization criteria (Adapted from WHO[@b10-jnm-24-226]).

NERD, non-erosive reflux disease; RE, reflux esophagitis; *H. pylori*, *Helicobacter pylori*.

###### 

Endoscopic Characteristics of Patients in the Study

  Variables                                            Dyspepsia (n = 215)   NERD (n = 55)   RE (n = 61)   *P*-value
  ---------------------------------------------------- --------------------- --------------- ------------- -----------
  Gastroesophageal flap valve (n \[%\])                                                                    \< 0.001
   Grade I                                             25 (11.6)             7 (12.7)        4 (6.6)       
   Grade II                                            131 (60.9)            24 (43.6)       20 (32.8)     
   Grade III                                           58 (27.0)             23 (41.8)       33 (54.1)     
   Grade IV                                            1 (0.5)               1 (1.8)         4 (6.6)       
  Endoscopic suspected Barrett's esophagus (n \[%\])   6 (2.8)               1 (1.8)         1 (1.6)       0.832
  Hiatus hernia (n \[%\])                              4 (1.9)               3 (5.5)         7 (11.5)      0.004
  Peptic ulcer diseases (n \[%\])                                                                          0.512
   Gastric ulcer                                       1 (0.5)               0               1 (1.6)       
   Duodenal ulcer                                      6 (2.8)               1 (1.8)         0             
  Atrophic gastritis (n \[%\])                                                                             0.830
   None/mild                                           210 (97.7)            53 (96.4)       59 (96.7)     
   Moderate                                            5 (2.3)               2 (3.6)         2 (3.3)       
   Severe                                              0                     0               0             

NERD, non-erosive reflux disease; RE, reflux esophagitis.

###### 

Risk Factors for Gastroesophageal Reflux Disease: Multivariable Analysis

                                                              Odds ratio   95% confidence interval   *P*-value
  ----------------------------------------------------------- ------------ ------------------------- -----------
  Gender (male)                                               1.68         0.78--3.62                0.190
  Age (≥ 60)                                                  4.32         1.05--17.77               0.043
  Obesity[a](#tfn4-jnm-24-226){ref-type="table-fn"}           1.93         0.97--3.86                0.062
  Central obesity[a](#tfn4-jnm-24-226){ref-type="table-fn"}   1.46         0.79--2.68                0.226
  Smoking                                                     2.51         1.23--5.1                 0.010
  Alcohol drinking                                            0.71         0.35--1.44                0.358
  Abnormal gastroesophagel flap valve                         2.93         1.76--4.88                \< 0.001
  *H. pylori* infection                                       0.49         0.29--0.82                0.007
  Moderate gastric atrophy                                    1.48         0.32--6.75                0.626

Obesity was defined as body mass index (BMI) \> 25kg/m^2^ and central obesity was defined as waist-hip ratio (WHR) ≥ 0.9 in male or ≥ 0.85 in female according to the World Health Organization criteria (Adapted from WHO [@b10-jnm-24-226] ).

*H. pylori*, *Helicobacter pylori*.

###### 

Risk Factors for Reflux Esophagitis: Multivariable Analysis

                                                              Odds ratio   95% confidence interval   *P*-value
  ----------------------------------------------------------- ------------ ------------------------- -----------
  Gender (male)                                               1.87         0.7--5.01                 0.210
  Age ≥ 60                                                    3.46         0.62--19.35               0.163
  Obesity[a](#tfn6-jnm-24-226){ref-type="table-fn"}           2.59         1.15--5.85                0.024
  Central obesity[a](#tfn6-jnm-24-226){ref-type="table-fn"}   1.64         0.76--3.55                0.216
  Smoking                                                     2.45         1.06--5.69                0.041
  Alcohol drinking                                            0.73         0.31--1.73                0.471
  Abnormal gastroesophagel flap valve                         3.41         1.78--6.53                \< 0.001
  *H. pylori* infection                                       0.16         0.07--0.36                \< 0.001
  Moderate gastric atrophy                                    1.56         0.2--12.37                0.673

Obesity was defined as body mass index (BMI) \> 25kg/m^2^ and central obesity was defined as waist--hip ratio (WHR) ≥ 0.9 in male or ≥ 0.85 in female according to the World Health Organization criteria (Adapted from WHO [@b10-jnm-24-226] ).

*H. pylori*, *Helicobacter pylori*.

###### 

Gastroesophageal Reflux Disease Questionnaire Score of Patients With Normal and Abnormal Gastroesophageal Flap Valve

                            Normal GEFV (n = 211)   Abnormal GEFV (n = 120)   *P*-value
  ------------------------- ----------------------- ------------------------- -----------
  GERDQ score (mean ± SD)   4.9 ± 2.4               5.7 ± 2.7                 0.011
  GERDQ score (n \[%\])                                                       
   \< 8                     177 (83.9)              84 (70.0)                 0.003
   ≥ 8                      34 (16.1)               36 (30.0)                 

GEFV, gastroesophageal flap valve; GERDQ, gastroesophageal reflux disease questionnaire.
